(Total Views: 867)
Posted On: 01/10/2022 11:40:15 AM
Post# of 154859
Regnum is now run by Anne Kirby, former Executive Vice President-Commercial & Operations at Vyera Pharmaceuticals.
So, it looks like this is just a new start for a small group of people within Vyera to build out a sales force to sell leronlimab. I wonder if it will still be called Vyrologix now that Vyera is out. Maybe Regnum will market leronlimab as Rex, king of all biologics.
Regnum RGMP stock up 363% today on the news.
Regnum will need to be capitalized in order to be able to hire people to sell leronlimab, err, I mean Rex, assuming we have everything in order and FDA finally agrees.
Regnum 10-Q:
https://www.sec.gov/Archives/edgar/data/17163...mp_10q.htm
It may be a blessing that Vyera is out of the picture, in name at least:
https://ag.ny.gov/press-release/2021/attorney...-corporate
So, it looks like this is just a new start for a small group of people within Vyera to build out a sales force to sell leronlimab. I wonder if it will still be called Vyrologix now that Vyera is out. Maybe Regnum will market leronlimab as Rex, king of all biologics.
Regnum RGMP stock up 363% today on the news.
Regnum will need to be capitalized in order to be able to hire people to sell leronlimab, err, I mean Rex, assuming we have everything in order and FDA finally agrees.
Regnum 10-Q:
https://www.sec.gov/Archives/edgar/data/17163...mp_10q.htm
It may be a blessing that Vyera is out of the picture, in name at least:
https://ag.ny.gov/press-release/2021/attorney...-corporate
(3)
(0)
